Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
125 participants
OBSERVATIONAL
2022-02-01
2023-01-05
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Validity and Reliability of the Expectation Scale in the Treatment of Chronic Pain
NCT04222036
Pain Types and Pain Severity in Chronic Low Back Pain
NCT05604027
Turkish Version of the Worry About Pain Questionnaire
NCT06052228
Validity, Reliability and Responsiveness of Pain Sensitization Questionnaire
NCT04162730
Reliability and Cross-cultural Adaptation of the Turkish Version of the Neuropathic Pain Symptom Inventory
NCT03544619
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_ONLY
CROSS_SECTIONAL
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Patients with chronic pain
Patients with non-cancer pain of more than 3 months duration.
Pain Modulation Index
A 18 item questionnaire assessing patients' pain characteristics for the detection of disordered pain modulation processes.
Pain Detect
A questionnaire that was validated for the assessment of neuropathic pain
Central sensitization inventory
A questionnaire developed for the detection of central sensitization.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Pain Modulation Index
A 18 item questionnaire assessing patients' pain characteristics for the detection of disordered pain modulation processes.
Pain Detect
A questionnaire that was validated for the assessment of neuropathic pain
Central sensitization inventory
A questionnaire developed for the detection of central sensitization.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* Refusal to take part in the study
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Ege University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Ece Cinar
Assistant Professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Simin Hepguler, Prof
Role: PRINCIPAL_INVESTIGATOR
Ege University Hospital
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Ege University Hospital, Department of Physical and rehabilitation medicine
Bornova, İzmir, Turkey (Türkiye)
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Austin PD, Asghari A, Costa DSJ, Siddall PJ. The development of a novel questionnaire assessing alterations in central pain processing in people with and without chronic pain. Scand J Pain. 2020 Apr 28;20(2):407-417. doi: 10.1515/sjpain-2019-0087.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
21-7T/44
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.